Boston Scientific Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $8.57B | $19.28B | $865.0M |
| FY2024 | $8.97B | $21.77B | $414.0M |
| FY2025 | $11.14B | $24.23B | $1.97B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $8.57B | $19.28B | $865.0M |
| FY2024 | $8.97B | $21.77B | $414.0M |
| FY2025 | $11.14B | $24.23B | $1.97B |